Comment in:

Ann Intern Med. 2009 Feb 3;150(3):220-1; author reply 221-2.

Ann Intern Med. 2009 Feb 3;150(3):221; author reply 221-2.

J Fam Pract. 2008 Nov;57(11):710.

Summary for patients in:

Ann Intern Med. 2008 Aug 5;149(3):I37.

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Calonge N, Petitti DB, DeWitt TG, Dietrich AJ, Gregory KD, Harris R, Isham GJ, LeFevre ML, Leipzig R, Loveland-Cherry C, Marion LN, Melnyk B, Moyer VA, Ockene JK, Sawaya GF, Yawn BP.

DESCRIPTION: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer. METHODS: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation. RECOMMENDATIONS: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).

PMID: 18678845 [PubMed - indexed for MEDLINE]